ERVW-1 and glioblastoma: Valproic acid (VPA) upregulates HERV-W and ERV9 transcription in a dose-dependent manner, with HERV-W showing the strongest response in glioblastoma cell lines, while HERV-K (HML-2) transcription remains unaffected (Diem et al., 2012).